{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:48:38Z","timestamp":1792900118273,"version":"4.5.0"},"reference-count":139,"publisher":"Siapec Servizi Srl","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologica"],"DOI":"10.32074\/1591-951x-954","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T15:17:26Z","timestamp":1701875846000},"page":"248-256","source":"Crossref","is-referenced-by-count":6,"title":["COVID-19. Biology, pathophysiology, and immunology: a pathologist view"],"prefix":"10.32074","volume":"115","author":[{"given":"Marco","family":"Chilosi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Doglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Ravaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Piciucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Dubini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Stefanizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venerino","family":"Poletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21774","published-online":{"date-parts":[[2023,10]]},"reference":[{"key":"10.32074\/1591-951X-954_ref1","doi-asserted-by":"crossref","unstructured":"Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"10.32074\/1591-951X-954_ref2","doi-asserted-by":"crossref","unstructured":"Fajgenbaum DC, June CH. Cytokine Storm. N Engl J Med 2020; 383: 2255-2573. https:\/\/doi.org\/10.1056\/NEJMra2026131","DOI":"10.1056\/NEJMra2026131"},{"key":"10.32074\/1591-951X-954_ref3","doi-asserted-by":"crossref","unstructured":"Zhou Y, Fu B, Zheng X, et al. Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients. Natl Sci Rev 2020; 7: 998-1002. https:\/\/doi.org\/10.1093\/nsr\/nwaa041","DOI":"10.1093\/nsr\/nwaa041"},{"key":"10.32074\/1591-951X-954_ref4","doi-asserted-by":"crossref","unstructured":"Han L, Zhuang MW, Deng J, et al. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I\/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways. J Med Virol 2021; 93: 5376-5389. https:\/\/doi.org\/10.1002\/jmv.27050","DOI":"10.1002\/jmv.27050"},{"key":"10.32074\/1591-951X-954_ref5","doi-asserted-by":"crossref","unstructured":"Han L, Zheng Y, Deng J, et al. SARS-CoV-2 ORF10 antagonizes STING-dependent interferon activation and autophagy. J Med Virol 2022; 94: 5174-5188. https:\/\/doi.org\/10.1002\/jmv.27965","DOI":"10.1002\/jmv.27965"},{"key":"10.32074\/1591-951X-954_ref6","doi-asserted-by":"crossref","unstructured":"Deng J, Zheng Y, Zheng SN, et al. SARS-CoV-2 NSP7 inhibits type I and III IFN production by targeting the RIG-I\/MDA5, TRIF, and STING signaling pathways. J Med Virol 2023; 95: e28561. https:\/\/doi.org\/10.1002\/jmv.28680","DOI":"10.1002\/jmv.28561"},{"key":"10.32074\/1591-951X-954_ref7","doi-asserted-by":"crossref","unstructured":"Cai S, Zhang C, Zhuang Z, et al. Phase-separated nucleocapsid protein of SARS-CoV-2 suppresses cGAS-DNA recognition by disrupting cGAS-G3BP1 complex. Signal Transduct Target Ther 2023; 8: 170. https:\/\/doi.org\/10.1038\/s41392-023-01420-9","DOI":"10.1038\/s41392-023-01420-9"},{"key":"10.32074\/1591-951X-954_ref8","doi-asserted-by":"crossref","unstructured":"Shu C, Li X, Li P. The mechanism of double-stranded DNA sensing through the cGAS-STING pathway. Cytokine Growth Factor Rev 2014; 25: 641-648. https:\/\/doi.org\/10.1016\/j.cytogfr.2014.06.006","DOI":"10.1016\/j.cytogfr.2014.06.006"},{"key":"10.32074\/1591-951X-954_ref9","doi-asserted-by":"crossref","unstructured":"Zeng PH, Yin WJ. The cGAS\/STING signaling pathway: a cross-talk of infection, senescence and tumors. Cell Cycle 2023; 22: 38-56. https:\/\/doi.org\/10.1080\/15384101.2022.2109899","DOI":"10.1080\/15384101.2022.2109899"},{"key":"10.32074\/1591-951X-954_ref10","doi-asserted-by":"crossref","unstructured":"Hornung V, Hartmann R, Ablasser A, et al. OAS proteins and cGAS: unifying concepts in sensing and responding to cytosolic nucleic acids. Nat Rev Immunol 2014; 14: 521-528. https:\/\/doi.org\/10.1038\/nri3719","DOI":"10.1038\/nri3719"},{"key":"10.32074\/1591-951X-954_ref11","doi-asserted-by":"crossref","unstructured":"Liu W, Reyes HM, Yang JF, et al. Activation of STING Signaling Pathway Effectively Blocks Human Coronavirus Infection. J Virol 2021; 95: e00490-21. https:\/\/doi.org\/10.1128\/JVI.00490-21","DOI":"10.1128\/JVI.00490-21"},{"key":"10.32074\/1591-951X-954_ref12","doi-asserted-by":"crossref","unstructured":"Neufeldt CJ, Cerikan B, Cortese M, et al. SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-\u03baB. Commun Biol 2022; 5: 45. https:\/\/doi.org\/10.1038\/s42003-021-02983-5","DOI":"10.1038\/s42003-021-02983-5"},{"key":"10.32074\/1591-951X-954_ref13","doi-asserted-by":"crossref","unstructured":"Di Domizio JD, Gulen MF, Saidoune F, et al. The cGAS-STING pathway drives type I IFN immunopathology in COVID-19. Nature 2022; 603: 145-151. https:\/\/doi.org\/10.1038\/s41586-022-04421-w","DOI":"10.1038\/s41586-022-04421-w"},{"key":"10.32074\/1591-951X-954_ref14","doi-asserted-by":"crossref","unstructured":"Andreakos E. STINGing type I IFN-mediated immunopathology in COVID-19. Nat Immunol 2022; 23: 478-480. https:\/\/doi.org\/10.1038\/s41590-022-01174-6","DOI":"10.1038\/s41590-022-01174-6"},{"key":"10.32074\/1591-951X-954_ref15","doi-asserted-by":"crossref","unstructured":"Xie J, Li Y, Shen X, et al. Dampened STING-Dependent Interferon Activation in Bats. Cell Host Microbe 2018; 23: 297-301.e4. https:\/\/doi.org\/10.1016\/j.chom.2018.01.006","DOI":"10.1016\/j.chom.2018.01.006"},{"key":"10.32074\/1591-951X-954_ref16","doi-asserted-by":"crossref","unstructured":"Sa Ribero M, Jouvenet N, Dreux M, et al. Interplay between SARS-CoV-2 and the type I interferon response. PLoS Pathog 2020; 16: e1008737. https:\/\/doi.org\/10.1371\/journal.ppat.1008737","DOI":"10.1371\/journal.ppat.1008737"},{"key":"10.32074\/1591-951X-954_ref17","doi-asserted-by":"crossref","unstructured":"Xia H, Cao Z, Xie X, et al. Evasion of Type I Interferon by SARS-CoV-2. Cell Rep 2020; 33: 108234. https:\/\/doi.org\/10.1016\/j.celrep.2020.108234","DOI":"10.1016\/j.celrep.2020.108234"},{"key":"10.32074\/1591-951X-954_ref18","doi-asserted-by":"crossref","unstructured":"Yuen CK, Lam JY, Wong WM, et al. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists. Emerg Microbes Infect 2020; 9: 1418-1428. https:\/\/doi.org\/10.1080\/22221751.2020.1780953","DOI":"10.1080\/22221751.2020.1780953"},{"key":"10.32074\/1591-951X-954_ref19","doi-asserted-by":"crossref","unstructured":"Wen W, Su W, Tang H, et al. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov 2020; 6: 31. https:\/\/doi.org\/10.1038\/s41421-020-0168-9","DOI":"10.1038\/s41421-020-00187-5"},{"key":"10.32074\/1591-951X-954_ref20","doi-asserted-by":"crossref","unstructured":"Trombetta AC, Farias GB, Gomes AMC, et al. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype. Front Immunol 2021; 12: 691725. https:\/\/doi.org\/10.3389\/fimmu.2021.691725","DOI":"10.3389\/fimmu.2021.691725"},{"key":"10.32074\/1591-951X-954_ref21","doi-asserted-by":"crossref","unstructured":"Ait-Belkacem I, Cartagena Garc\u00eda C, Millet-Wallisky E, et al. SARS-CoV-2 spike protein induces a differential monocyte activation that may contribute to age bias in COVID-19 severity. Sci Rep 2022; 12: 20824. https:\/\/doi.org\/10.1038\/s41598-022-25259-2","DOI":"10.1038\/s41598-022-25259-2"},{"key":"10.32074\/1591-951X-954_ref22","doi-asserted-by":"crossref","unstructured":"Bost P, De Sanctis F, Can\u00e8 S, et al. Deciphering the state of immune silence in fatal COVID-19 patients. Nat Commun 2021; 12: 1428. https:\/\/doi.org\/10.1038\/s41467-021-21702-6","DOI":"10.1038\/s41467-021-21702-6"},{"key":"10.32074\/1591-951X-954_ref23","doi-asserted-by":"crossref","unstructured":"Falck-Jones S, \u00d6sterberg B, Smed-S\u00f6rensen A. Respiratory and systemic monocytes, dendritic cells, and myeloid-derived suppressor cells in COVID-19: Implications for disease severity. J Intern Med 2023; 293: 130-143. https:\/\/doi.org\/10.1111\/joim.13559","DOI":"10.1111\/joim.13559"},{"key":"10.32074\/1591-951X-954_ref24","doi-asserted-by":"crossref","unstructured":"Fan YM, Zhang YL, Luo H, et al. Crosstalk between RNA viruses and DNA sensors: Role of the cGAS-STING signalling pathway. Rev Med Virol 2022; 32: e2343. https:\/\/doi.org\/10.1002\/rmv.2343","DOI":"10.1002\/rmv.2343"},{"key":"10.32074\/1591-951X-954_ref25","doi-asserted-by":"crossref","unstructured":"Amurri L, Horvat B, Iampietro M. Interplay between RNA viruses and cGAS\/STING axis in innate immunity. Front Cell Infect Microbiol 2023; 13: 1172739. https:\/\/doi.org\/10.3389\/fcimb.2023.1172739","DOI":"10.3389\/fcimb.2023.1172739"},{"key":"10.32074\/1591-951X-954_ref26","doi-asserted-by":"crossref","unstructured":"Augusto DG, Murdolo LD, Chatzileontiadou DSM, et al. A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection. Nature 2023; 620: 128-136. https:\/\/doi.org\/10.1038\/s41586-023-06331-x","DOI":"10.1038\/s41586-023-06331-x"},{"key":"10.32074\/1591-951X-954_ref27","doi-asserted-by":"crossref","unstructured":"Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054-1062. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"10.32074\/1591-951X-954_ref28","doi-asserted-by":"crossref","unstructured":"Bai J, Cervantes C, Liu J, et al. DsbA-L prevents obesity-induced inflammation and insulin resistance by suppressing the mtDNA release-activated cGAS-cGAMP-STING pathway. Proc Natl Acad Sci U S A 2017; 114: 12196-12201. https:\/\/doi.org\/10.1073\/pnas.1708744114","DOI":"10.1073\/pnas.1708744114"},{"key":"10.32074\/1591-951X-954_ref29","doi-asserted-by":"crossref","unstructured":"Schmitz CRR, Maurmann RM, Guma FTCR, et al. cGAS-STING pathway as a potential trigger of immunosenescence and inflammaging. Front Immunol 2023; 14: 1132653. https:\/\/doi.org\/10.3389\/fimmu.2023.1132653","DOI":"10.3389\/fimmu.2023.1132653"},{"key":"10.32074\/1591-951X-954_ref30","doi-asserted-by":"crossref","unstructured":"Zheng W, Feng D, Xiong X, et al. The Role of cGAS-STING in Age-Related Diseases from Mechanisms to Therapies. Aging Dis 2023; 14: 1145-1165. https:\/\/doi.org\/10.14336\/AD.2023.0117","DOI":"10.14336\/AD.2023.0117"},{"key":"10.32074\/1591-951X-954_ref31","doi-asserted-by":"crossref","unstructured":"Elzinga SE, Henn R, Murdock BJ, et al. cGAS\/STING and innate brain inflammation following acute high-fat feeding. Front Immunol 2022; 13: 1012594. https:\/\/doi.org\/10.3389\/fimmu.2022.1012594","DOI":"10.3389\/fimmu.2022.1012594"},{"key":"10.32074\/1591-951X-954_ref32","doi-asserted-by":"crossref","unstructured":"Hu H, Zhao R, He Q, et al. cGAS-STING mediates cytoplasmic mitochondrial-DNA-induced inflammatory signal transduction during accelerated senescence of pancreatic \u03b2-cells induced by metabolic stress. FASEB J 2022; 36: e22266. https:\/\/doi.org\/10.1096\/fj.202101988R","DOI":"10.1096\/fj.202101988R"},{"key":"10.32074\/1591-951X-954_ref33","doi-asserted-by":"crossref","unstructured":"Zang N, Cui C, Guo X, et al. cGAS-STING activation contributes to podocyte injury in diabetic kidney disease. iScience 2022; 25: 105145. https:\/\/doi.org\/10.1016\/j.isci.2022.105145","DOI":"10.1016\/j.isci.2022.105145"},{"key":"10.32074\/1591-951X-954_ref34","doi-asserted-by":"crossref","unstructured":"Hadjadj J, Yatim N, Barnabei L, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 2020; 369: 718-724. https:\/\/doi.org\/10.1126\/science.abc6027","DOI":"10.1126\/science.abc6027"},{"key":"10.32074\/1591-951X-954_ref35","doi-asserted-by":"crossref","unstructured":"Zhang Q, Bastard P, Liu Z, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 2020; 370: eabd4570. https:\/\/doi.org\/10.1126\/science.abd4570","DOI":"10.1126\/science.abd4570"},{"key":"10.32074\/1591-951X-954_ref36","doi-asserted-by":"crossref","unstructured":"Zhang Q, Bastard P; COVID Human Genetic Effort; et al. Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature 2022; 603:587-598. https:\/\/doi.org\/10.1038\/s41586-022-04447-0","DOI":"10.1038\/s41586-022-04447-0"},{"key":"10.32074\/1591-951X-954_ref37","doi-asserted-by":"crossref","unstructured":"Matuozzo D, Talouarn E, Marchal A, et al. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19. Genome Med 2023; 15: 22. https:\/\/doi.org\/10.1186\/s13073-023-01173-8","DOI":"10.1186\/s13073-023-01173-8"},{"key":"10.32074\/1591-951X-954_ref38","doi-asserted-by":"crossref","unstructured":"Casanova JL, Anderson MS. Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs. J Clin Invest 2023; 133: e166283. https:\/\/doi.org\/10.1172\/JCI166283","DOI":"10.1172\/JCI166283"},{"key":"10.32074\/1591-951X-954_ref39","doi-asserted-by":"crossref","unstructured":"Bastard P, Rosen LB, Zhang Q, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 2020; 370: eabd4585. https:\/\/doi.org\/10.1126\/science.abd4585","DOI":"10.1126\/science.abd4585"},{"key":"10.32074\/1591-951X-954_ref40","doi-asserted-by":"crossref","unstructured":"Zhou W, Wang W. Auto-antibodies against type I IFNs are associated with severe COVID-19 pneumonia. Signal Transduct Target Ther 2021; 6: 96. https:\/\/doi.org\/10.1038\/s41392-021-00514-6","DOI":"10.1038\/s41392-021-00514-6"},{"key":"10.32074\/1591-951X-954_ref41","doi-asserted-by":"crossref","unstructured":"Philippot Q, Fekkar A, Gervais A, et al. J Clin Immunol 2023; 43: 1093-1103. https:\/\/doi.org\/10.1007\/s10875-023-01512-9","DOI":"10.1007\/s10875-023-01512-9"},{"key":"10.32074\/1591-951X-954_ref42","doi-asserted-by":"crossref","unstructured":"Simula ER, Manca MA, Noli M, et al. Increased Presence of Antibodies against Type I Interferons and Human Endogenous Retrovirus W in Intensive Care Unit COVID-19 Patients. Microbiol Spectr 2022; 10: e0128022. https:\/\/doi.org\/10.1128\/spectrum.01280-22","DOI":"10.1128\/spectrum.01280-22"},{"key":"10.32074\/1591-951X-954_ref43","doi-asserted-by":"crossref","unstructured":"Tokuyama M, Kong Y, Song E, et al. ERVmap analysis reveals genome-wide transcription of human endogenous retroviruses. Proc Natl Acad Sci U S A 2018; 115: 12565-12572. https:\/\/doi.org\/10.1073\/pnas.1814589115","DOI":"10.1073\/pnas.1814589115"},{"key":"10.32074\/1591-951X-954_ref44","doi-asserted-by":"crossref","unstructured":"Perl A. Role of endogenous retroviruses in autoimmune diseases. Rheum Dis Clin North Am 2003; 29: 123-43, vii. https:\/\/doi.org\/10.1016\/s0889-857x(02)00098-4","DOI":"10.1016\/S0889-857X(02)00098-4"},{"key":"10.32074\/1591-951X-954_ref45","doi-asserted-by":"crossref","unstructured":"Perl A, Nagy G, Koncz A, et al. Molecular mimicry and immunomodulation by the HRES-1 endogenous retrovirus in SLE. Autoimmunity 2008; 41: 287-97. https:\/\/doi.org\/10.1080\/08916930802024764","DOI":"10.1080\/08916930802024764"},{"key":"10.32074\/1591-951X-954_ref46","doi-asserted-by":"crossref","unstructured":"Volkman HE, Stetson DB. The enemy within: endogenous retroelements and autoimmune disease. Nat Immunol 2014; 15: 415-422. https:\/\/doi.org\/10.1038\/ni.2872","DOI":"10.1038\/ni.2872"},{"key":"10.32074\/1591-951X-954_ref47","doi-asserted-by":"crossref","unstructured":"Stein RA, DePaola RV. Human endogenous retroviruses: our genomic fossils and companions. Physiol Genomics 2023; 55: 249-258. https:\/\/doi.org\/10.1152\/physiolgenomics.00171.2022","DOI":"10.1152\/physiolgenomics.00171.2022"},{"key":"10.32074\/1591-951X-954_ref48","doi-asserted-by":"crossref","unstructured":"Dolei A. The aliens inside us: HERV-W endogenous retroviruses and multiple sclerosis. Mult Scler 2018; 24: 42-47. https:\/\/doi.org\/10.1177\/1352458517737370","DOI":"10.1177\/1352458517737370"},{"key":"10.32074\/1591-951X-954_ref49","doi-asserted-by":"crossref","unstructured":"Gruchot J, Herrero F, Weber-Stadlbauer U, et al. Interplay between activation of endogenous retroviruses and inflammation as common pathogenic mechanism in neurological and psychiatric disorders. Brain Behav Immun 2023; 107: 242-252. https:\/\/doi.org\/10.1016\/j.bbi.2022.10.007","DOI":"10.1016\/j.bbi.2022.10.007"},{"key":"10.32074\/1591-951X-954_ref50","doi-asserted-by":"crossref","unstructured":"Hartung HP, Derfuss T, Cree BA, et al. Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study. Mult Scler 2022; 28: 429-440. https:\/\/doi.org\/10.1177\/13524585211024997","DOI":"10.1177\/13524585211024997"},{"key":"10.32074\/1591-951X-954_ref51","doi-asserted-by":"crossref","unstructured":"Ng KW, Boumelha J, Enfield KSS, et al. Antibodies against endogenous retroviruses promote lung cancer immunotherapy. Nature 2023; 616: 563-573. https:\/\/doi.org\/10.1038\/s41586-023-05771-9","DOI":"10.1038\/s41586-023-05771-9"},{"key":"10.32074\/1591-951X-954_ref52","doi-asserted-by":"crossref","unstructured":"Balestrieri E, Minutolo A, Petrone V, et al. Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients. EBioMedicine 2021; 66: 103341. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103341","DOI":"10.1016\/j.ebiom.2021.103341"},{"key":"10.32074\/1591-951X-954_ref53","doi-asserted-by":"crossref","unstructured":"Temerozo JR, Fintelman-Rodrigues N, Dos Santos MC, et al. Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology. Microbiome 2022; 10: 65. https:\/\/doi.org\/10.1186\/s40168-022-01260-9","DOI":"10.1186\/s40168-022-01260-9"},{"key":"10.32074\/1591-951X-954_ref54","doi-asserted-by":"crossref","unstructured":"Gim\u00e9nez-Orenga K, Pierquin J, Brunel J, et al. HERV-W ENV antigenemia and correlation of increased anti-SARS-CoV-2 immunoglobulin levels with post-COVID-19 symptoms. Front Immunol 2022; 13: 1020064. https:\/\/doi.org\/10.3389\/fimmu.2022.1020064","DOI":"10.3389\/fimmu.2022.1020064"},{"key":"10.32074\/1591-951X-954_ref55","doi-asserted-by":"crossref","unstructured":"Petrone V, Fanelli M, Giudice M, et al. Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity. Front Microbiol 2023; 14: 1155624. https:\/\/doi.org\/10.3389\/fmicb.2023.1155624","DOI":"10.3389\/fmicb.2023.1155624"},{"key":"10.32074\/1591-951X-954_ref56","doi-asserted-by":"crossref","unstructured":"Grandi N, Erb\u00ec MC, Scognamiglio S, et al. Human Endogenous Retrovirus (HERV) Transcriptome Is Dynamically Modulated during SARS-CoV-2 Infection and Allows Discrimination of COVID-19 Clinical Stages. Microbiol Spectr 2023; 11: e0251622. https:\/\/doi.org\/10.1128\/spectrum.02516-22","DOI":"10.1128\/spectrum.02516-22"},{"key":"10.32074\/1591-951X-954_ref57","doi-asserted-by":"crossref","unstructured":"Grandi N, Tramontano E. Type W Human Endogenous Retrovirus (HERV-W) Integrations and Their Mobilization by L1 Machinery: Contribution to the Human Transcriptome and Impact on the Host Physiopathology. Viruses 2017; 9: 162. https:\/\/doi.org\/10.3390\/v9070162","DOI":"10.3390\/v9070162"},{"key":"10.32074\/1591-951X-954_ref58","doi-asserted-by":"crossref","unstructured":"Charvet B, Brunel J, Pierquin J, et al. SARS-CoV-2 awakens ancient retroviral genes and the expression of proinflammatory HERV-W envelope protein in COVID-19 patients. iScience 2023; 26: 106604. https:\/\/doi.org\/10.1016\/j.isci.2023.106604","DOI":"10.1016\/j.isci.2023.106604"},{"key":"10.32074\/1591-951X-954_ref59","doi-asserted-by":"crossref","unstructured":"Grandi N, Tramontano E. Human Endogenous Retroviruses Are Ancient Acquired Elements Still Shaping Innate Immune Responses. Front Immunol 2018; 9: 2039. https:\/\/doi.org\/10.3389\/fimmu.2018.02039","DOI":"10.3389\/fimmu.2018.02039"},{"key":"10.32074\/1591-951X-954_ref60","doi-asserted-by":"crossref","unstructured":"Li X, Wu X, Li W, et al. HERV-W ENV Induces Innate Immune Activation and Neuronal Apoptosis via linc01930\/cGAS Axis in Recent-Onset Schizophrenia. Int J Mol Sci 2023; 24: 3000. https:\/\/doi.org\/10.3390\/ijms24033000","DOI":"10.3390\/ijms24033000"},{"key":"10.32074\/1591-951X-954_ref61","doi-asserted-by":"crossref","unstructured":"Sankowski R, Strohl JJ, Huerta TS, et al. Endogenous retroviruses are associated with hippocampus-based memory impairment. Proc Natl Acad Sci U S A 2019; 116: 25982-25990. https:\/\/doi.org\/10.1073\/pnas.1822164116","DOI":"10.1073\/pnas.1822164116"},{"key":"10.32074\/1591-951X-954_ref62","doi-asserted-by":"crossref","unstructured":"Bao H, Yan J, Huang J, et al. Activation of endogenous retrovirus triggers microglial immuno-inflammation and contributes to negative emotional behaviors in mice with chronic stress. J Neuroinflammation 2023; 20: 37. https:\/\/doi.org\/10.1186\/s12974-023-02724-x","DOI":"10.1186\/s12974-023-02724-x"},{"key":"10.32074\/1591-951X-954_ref63","doi-asserted-by":"crossref","unstructured":"Hurst TP, Magiorkinis G. Epigenetic Control of Human Endogenous Retrovirus Expression: Focus on Regulation of Long-Terminal Repeats (LTRs). Viruses 2017; 9: 130. https:\/\/doi.org\/10.3390\/v9060130","DOI":"10.3390\/v9060130"},{"key":"10.32074\/1591-951X-954_ref64","doi-asserted-by":"crossref","unstructured":"Cardelli M. The epigenetic alterations of endogenous retroelements in aging. Mech Ageing Dev 2018; 174: 30-46. https:\/\/doi.org\/10.1016\/j.mad.2018.02.002","DOI":"10.1016\/j.mad.2018.02.002"},{"key":"10.32074\/1591-951X-954_ref65","doi-asserted-by":"crossref","unstructured":"Di Giorgio E, Xodo LE. Endogenous Retroviruses (ERVs): Does RLR (RIG-I-Like Receptors)-MAVS Pathway Directly Control Senescence and Aging as a Consequence of ERV De-Repression? Front Immunol 2022; 13: 917998. https:\/\/doi.org\/10.3389\/fimmu.2022.917998","DOI":"10.3389\/fimmu.2022.917998"},{"key":"10.32074\/1591-951X-954_ref66","doi-asserted-by":"crossref","unstructured":"Liu X, Liu Z, Wu Z, et al. Resurrection of endogenous retroviruses during aging reinforces senescence. Cell 2023; 186: 287-304.e26. https:\/\/doi.org\/10.1016\/j.cell.2022.12.017","DOI":"10.1016\/j.cell.2022.12.017"},{"key":"10.32074\/1591-951X-954_ref67","doi-asserted-by":"crossref","unstructured":"Polak SB, Van Gool IC, Cohen D, et al. A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression. Mod Pathol 2020; 33: 2128-2138. https:\/\/doi.org\/10.1038\/s41379-020-0603-3","DOI":"10.1038\/s41379-020-0603-3"},{"key":"10.32074\/1591-951X-954_ref68","doi-asserted-by":"crossref","unstructured":"Mohanty SK, Satapathy A, Naidu MM, et al. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) - anatomic pathology perspective on current knowledge. Diagn Pathol 2020; 15: 103. DOI 10.1186\/s13000-020-01017-8","DOI":"10.1186\/s13000-020-01017-8"},{"key":"10.32074\/1591-951X-954_ref69","doi-asserted-by":"crossref","unstructured":"Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020; 8: 420-422. https:\/\/doi.org\/10.1016\/S2213-2600(20)30076-X","DOI":"10.1016\/S2213-2600(20)30076-X"},{"key":"10.32074\/1591-951X-954_ref70","doi-asserted-by":"crossref","unstructured":"Carsana L, Sonzogni A, Nasr A, et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis 2020; 20: 1135-1140. https:\/\/doi.org\/10.1016\/S1473-3099(20)30434-5","DOI":"10.1016\/S1473-3099(20)30434-5"},{"key":"10.32074\/1591-951X-954_ref71","doi-asserted-by":"crossref","unstructured":"Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med 2020; 383: 120-128. https:\/\/doi.org\/10.1056\/NEJMoa2015432","DOI":"10.1056\/NEJMoa2015432"},{"key":"10.32074\/1591-951X-954_ref72","doi-asserted-by":"crossref","unstructured":"Menter T, Haslbauer JD, Nienhold R, et al. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology 2020; 77: 198-209. https:\/\/doi.org\/10.1111\/his.14134","DOI":"10.1111\/his.14134"},{"key":"10.32074\/1591-951X-954_ref73","doi-asserted-by":"crossref","unstructured":"Gattinoni L, Coppola S, Cressoni M, et al. COVID-19 Does Not Lead to a \u201cTypical\u201d Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 2020; 201: 1299-1300. https:\/\/doi.org\/10.1164\/rccm.202003-0817LE","DOI":"10.1164\/rccm.202003-0817LE"},{"key":"10.32074\/1591-951X-954_ref74","doi-asserted-by":"crossref","unstructured":"Maley JH, Winkler T, Hardin CC. Heterogeneity of Acute Respiratory Distress Syndrome in COVID-19: \u201cTypical\u201d or Not? Am J Respir Crit Care Med; 202: 618-619. https:\/\/doi.org\/10.1164\/rccm.202004-1106LE","DOI":"10.1164\/rccm.202004-1106LE"},{"key":"10.32074\/1591-951X-954_ref75","doi-asserted-by":"crossref","unstructured":"Doglioni C, Ravaglia C, Chilosi M, et al. Covid-19 Interstitial Pneumonia: Histological and Immunohistochemical Features on Cryobiopsies. Respiration 2021; 100: 488-498. https:\/\/doi.org\/10.1159\/000514822","DOI":"10.1159\/000514822"},{"key":"10.32074\/1591-951X-954_ref76","doi-asserted-by":"crossref","unstructured":"Chilosi M, Poletti V, Ravaglia C, et al. The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime. Mod Pathol 2021; 34: 1444-1455. https:\/\/doi.org\/10.1038\/s41379-021-00808-8","DOI":"10.1038\/s41379-021-00808-8"},{"key":"10.32074\/1591-951X-954_ref77","doi-asserted-by":"crossref","unstructured":"Pfefferkorn ER, Rebhun S, Eckel M. Characterization of an indoleamine 2,3-dioxygenase induced by gamma-interferon in cultured human fibroblasts. J Interferon Res 1986; 6: 267-279. https:\/\/doi.org\/10.1089\/jir.1986.6.267","DOI":"10.1089\/jir.1986.6.267"},{"key":"10.32074\/1591-951X-954_ref78","doi-asserted-by":"crossref","unstructured":"Taylor MW, Feng GS. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 1991; 5: 2516-2522","DOI":"10.1096\/fasebj.5.11.1907934"},{"key":"10.32074\/1591-951X-954_ref79","doi-asserted-by":"crossref","unstructured":"Yeung AW, Terentis AC, King NJ, et al. Role of indoleamine 2,3-dioxygenase in health and disease. Clin Sci (Lond) 2015; 129: 601-672. https:\/\/doi.org\/10.1042\/CS20140392","DOI":"10.1042\/CS20140392"},{"key":"10.32074\/1591-951X-954_ref80","doi-asserted-by":"crossref","unstructured":"Sedlmayr P, Blaschitz A. Placental expression of indoleamine 2,3-dioxygenase. Wien Med Wochenschr 2012; 162: 214-219. https:\/\/doi.org\/10.1007\/s10354-012-0082-3","DOI":"10.1007\/s10354-012-0082-3"},{"key":"10.32074\/1591-951X-954_ref81","doi-asserted-by":"crossref","unstructured":"Wang Y, Liu H, McKenzie G, et al. Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nat Med 2010; 16: 279-285. https:\/\/doi.org\/10.1038\/nm.2092","DOI":"10.1038\/nm.2092"},{"key":"10.32074\/1591-951X-954_ref82","doi-asserted-by":"crossref","unstructured":"Zardoya-Laguardia P, Blaschitz A, Hirschmugl B, et al. Endothelial indoleamine 2,3-dioxygenase-1 regulates the placental vascular tone and is deficient in intrauterine growth restriction and pre-eclampsia. Sci Rep 2018; 8: 5488. https:\/\/doi.org\/10.1038\/s41598-018-23896-0","DOI":"10.1038\/s41598-018-23896-0"},{"key":"10.32074\/1591-951X-954_ref83","doi-asserted-by":"crossref","unstructured":"Nishizawa H, Pryor-Koishi K, Kato T, et al. Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia. Placenta 2007; 28: 487-497. https:\/\/doi.org\/10.1016\/j.placenta.2006.05.010","DOI":"10.1016\/j.placenta.2006.05.010"},{"key":"10.32074\/1591-951X-954_ref84","doi-asserted-by":"crossref","unstructured":"Nishizawa H, Ota S, Suzuki M, et al. Comparative gene expression profiling of placentas from patients with severe pre-eclampsia and unexplained fetal growth restriction. Reprod Biol Endocrinol 2011; 9: 107. https:\/\/doi.org\/10.1186\/1477-7827-9-107","DOI":"10.1186\/1477-7827-9-107"},{"key":"10.32074\/1591-951X-954_ref85","doi-asserted-by":"crossref","unstructured":"Santillan MK, Pelham CJ, Ketsawatsomkron P, et al. Pregnant mice lacking indoleamine 2,3-dioxygenase exhibit preeclampsia phenotypes. Physiol Rep 2015; 3: e12257. https:\/\/doi.org\/10.14814\/phy2.12257","DOI":"10.14814\/phy2.12257"},{"key":"10.32074\/1591-951X-954_ref86","doi-asserted-by":"crossref","unstructured":"Broekhuizen M, Hitzerd E, van den Bosch TPP, et al. The Placental Innate Immune System Is Altered in Early-Onset Preeclampsia, but Not in Late-Onset Preeclampsia. Front Immunol 2021; 12: 780043. https:\/\/doi.org\/10.3389\/fimmu.2021.780043","DOI":"10.3389\/fimmu.2021.780043"},{"key":"10.32074\/1591-951X-954_ref87","doi-asserted-by":"crossref","unstructured":"Watts SW, Shaw S, Burnett R, et al. Indoleamine 2,3-diooxygenase in periaortic fat: mechanisms of inhibition of contraction. Am J Physiol Heart Circ Physiol 2011; 301: H1236-47. https:\/\/doi.org\/10.1152\/ajpheart.00384.2011","DOI":"10.1152\/ajpheart.00384.2011"},{"key":"10.32074\/1591-951X-954_ref88","doi-asserted-by":"crossref","unstructured":"Struijk PC, Mathews VJ, Loupas T, et al. Blood pressure estimation in the human fetal descending aorta. Ultrasound Obstet Gynecol 2008; 32: 673-681. https:\/\/doi.org\/10.1002\/uog.6137","DOI":"10.1002\/uog.6137"},{"key":"10.32074\/1591-951X-954_ref89","doi-asserted-by":"crossref","unstructured":"Th\u00e9ate I, van Baren N, Pilotte L, et al. Extensive profiling of the expression of the indoleamine 2,3-dioxygenase 1 protein in normal and tumoral human tissues. Cancer Immunol Res 2015; 3: 161-172. https:\/\/doi.org\/10.1158\/2326-6066.CIR-14-0137","DOI":"10.1158\/2326-6066.CIR-14-0137"},{"key":"10.32074\/1591-951X-954_ref90","doi-asserted-by":"crossref","unstructured":"Xiao Y, Christou H, Liu L, et al. Endothelial indoleamine 2,3-dioxygenase protects against development of pulmonary hypertension. Am J Respir Crit Care Med 2013; 188: 482-491. https:\/\/doi.org\/10.1164\/rccm.201304-0700OC","DOI":"10.1164\/rccm.201304-0700OC"},{"key":"10.32074\/1591-951X-954_ref91","doi-asserted-by":"crossref","unstructured":"Liu H, Liu L, Visner GA. Nonviral gene delivery with indoleamine 2,3-dioxygenase targeting pulmonary endothelium protects against ischemia-reperfusion injury. Am J Transplant 2007; 7: 2291-300. https:\/\/doi.org\/10.1111\/j.1600-6143.2007.01942.x","DOI":"10.1111\/j.1600-6143.2007.01942.x"},{"key":"10.32074\/1591-951X-954_ref92","doi-asserted-by":"crossref","unstructured":"Cole JE, Astola N, Cribbs AP, et al. Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development. Proc Natl Acad Sci U S A 2015; 112: 13033-8. https:\/\/doi.org\/10.1073\/pnas.1517820112","DOI":"10.1073\/pnas.1517820112"},{"key":"10.32074\/1591-951X-954_ref93","doi-asserted-by":"crossref","unstructured":"Forteza MJ, Polyzos KA, Baumgartner R, et al. Activation of the Regulatory T-Cell\/Indoleamine 2,3-Dioxygenase Axis Reduces Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice. Front Immunol 2018; 9: 950. https:\/\/doi.org\/10.3389\/fimmu.2018.00950","DOI":"10.3389\/fimmu.2018.00950"},{"key":"10.32074\/1591-951X-954_ref94","doi-asserted-by":"crossref","unstructured":"Wolowczuk I, Hennart B, Leloire A, et al. Tryptophan metabolism activation by indoleamine 2,3-dioxygenase in adipose tissue of obese women: an attempt to maintain immune homeostasis and vascular tone. Am J Physiol Regul Integr Comp Physiol 2012; 303: R135-43. https:\/\/doi.org\/10.1152\/ajpregu.00373.2011","DOI":"10.1152\/ajpregu.00373.2011"},{"key":"10.32074\/1591-951X-954_ref95","doi-asserted-by":"crossref","unstructured":"Lee SM, Park HY, Suh YS, et al. Inhibition of acute lethal pulmonary inflammation by the IDO-AhR pathway. Proc Natl Acad Sci U S A 2017; 114: E5881-E5890. https:\/\/doi.org\/10.1073\/pnas.1615280114","DOI":"10.1073\/pnas.1615280114"},{"key":"10.32074\/1591-951X-954_ref96","doi-asserted-by":"crossref","unstructured":"Evans PC, Rainger GE, Mason JC, et al. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardiovasc Res 2020; 116: 2177-2184. https:\/\/doi.org\/10.1093\/cvr\/cvaa230","DOI":"10.1093\/cvr\/cvaa230"},{"key":"10.32074\/1591-951X-954_ref97","doi-asserted-by":"crossref","unstructured":"Potus F, Mai V, Lebret M, et al. Novel insights on the pulmonary vascular consequences of COVID-19. Am J Physiol Lung Cell Mol Physiol 2020; 319: L277-L288. https:\/\/doi.org\/10.1152\/ajplung.00195.2020","DOI":"10.1152\/ajplung.00195.2020"},{"key":"10.32074\/1591-951X-954_ref98","doi-asserted-by":"crossref","unstructured":"Bonaventura A, Vecchi\u00e9 A, Dagna L, et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol 2021; 21: 319-329. https:\/\/doi.org\/10.1038\/s41577-021-00536-9","DOI":"10.1038\/s41577-021-00536-9"},{"key":"10.32074\/1591-951X-954_ref99","doi-asserted-by":"crossref","unstructured":"Mejia-Renteria H, Travieso A, Sagir A, et al. In-vivo evidence of systemic endothelial vascular dysfunction in COVID-19. Int J Cardiol 2021; 345: 153-155. https:\/\/doi.org\/10.1016\/j.ijcard.2021.10.140","DOI":"10.1016\/j.ijcard.2021.10.140"},{"key":"10.32074\/1591-951X-954_ref100","doi-asserted-by":"crossref","unstructured":"Merlo LMF, Pigott E, DuHadaway JB, et al. IDO2 is a critical mediator of autoantibody production and inflammatory pathogenesis in a mouse model of autoimmune arthritis. J Immunol 2014; 192: 2082-2090. https:\/\/doi.org\/10.4049\/jimmunol.1303012","DOI":"10.4049\/jimmunol.1303012"},{"key":"10.32074\/1591-951X-954_ref101","doi-asserted-by":"crossref","unstructured":"Merlo LM, Mandik-Nayak L. IDO2: A Pathogenic Mediator of Inflammatory Autoimmunity. Clin Med Insights Pathol 2016; 9: 21-28. https:\/\/doi.org\/10.4137\/CPath.S39930","DOI":"10.4137\/CPath.S39930"},{"key":"10.32074\/1591-951X-954_ref102","doi-asserted-by":"crossref","unstructured":"Fatokun AA, Hunt NH, Ball HJ. Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease. Amino Acids 2013; 45: 1319-1329. https:\/\/doi.org\/10.1007\/s00726-013-1602-1","DOI":"10.1007\/s00726-013-1602-1"},{"key":"10.32074\/1591-951X-954_ref103","doi-asserted-by":"crossref","unstructured":"Guo L, Schurink B, Roos E, et al. Indoleamine 2,3-dioxygenase (IDO)-1 and IDO-2 activity and severe course of COVID-19. J Pathol 2022; 256: 256-261. https:\/\/doi.org\/10.1002\/path.5842","DOI":"10.1002\/path.5842"},{"key":"10.32074\/1591-951X-954_ref104","doi-asserted-by":"crossref","unstructured":"Chilosi M, Doglioni C, Ravaglia C, et al. Unbalanced IDO1\/IDO2 Endothelial Expression and Skewed Keynurenine Pathway in the Pathogenesis of COVID-19 and Post-COVID-19 Pneumonia. Biomedicines 2022; 10: 1332. https:\/\/doi.org\/10.3390\/biomedicines10061332","DOI":"10.3390\/biomedicines10061332"},{"key":"10.32074\/1591-951X-954_ref105","doi-asserted-by":"crossref","unstructured":"Wang D, Gomes MT, Mo Y, et al. Human Endogenous Retrovirus, SARS-CoV-2, and HIV Promote PAH via Inflammation and Growth Stimulation. Int J Mol Sci 2023; 24: 7472. https:\/\/doi.org\/10.3390\/ijms24087472","DOI":"10.3390\/ijms24087472"},{"key":"10.32074\/1591-951X-954_ref106","doi-asserted-by":"crossref","unstructured":"Li Q, Huang XT, Li CH, et al. CT features of coronavirus disease 2019 (COVID-19) with an emphasis on the vascular enlargement pattern. Eur J Radiol 2021; 134: 109442. https:\/\/doi.org\/10.1016\/j.ejrad.2020.109442","DOI":"10.1016\/j.ejrad.2020.109442"},{"key":"10.32074\/1591-951X-954_ref107","doi-asserted-by":"crossref","unstructured":"Lang M, Som A, Carey D, et al. Pulmonary Vascular Manifestations of COVID-19 Pneumonia. Radiol Cardiothorac Imaging 2020; 2: e200277. https:\/\/doi.org\/10.1148\/ryct.2020200277","DOI":"10.1148\/ryct.2020200277"},{"key":"10.32074\/1591-951X-954_ref108","doi-asserted-by":"crossref","unstructured":"Piciucchi S, Ravaglia C, Vizzuso A, et al. Reversibility of venous dilatation and parenchymal changes density in Sars-Cov-2 pneumonia: toward the definition of a peculiar pattern. Pulmonology 2021; 27: 353-357. https:\/\/doi.org\/10.1016\/j.pulmoe.2020.10.010","DOI":"10.1016\/j.pulmoe.2020.10.010"},{"key":"10.32074\/1591-951X-954_ref109","doi-asserted-by":"crossref","unstructured":"Gattinoni L, Chiumello D, Caironi P, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med 2020; 46: 1099-1102. https:\/\/doi.org\/10.1007\/s00134-020-06033-2","DOI":"10.1007\/s00134-020-06033-2"},{"key":"10.32074\/1591-951X-954_ref110","doi-asserted-by":"crossref","unstructured":"Busana M, Schiavone M, Lanfranchi A, et al. Non-invasive hemodynamic profile of early COVID-19 infection. Physiol Rep 2020; 8: e14628. https:\/\/doi.org\/10.14814\/phy2.14628","DOI":"10.14814\/phy2.14628"},{"key":"10.32074\/1591-951X-954_ref111","doi-asserted-by":"crossref","unstructured":"Oldani S, Ravaglia C, Bensai S, et al. Pathophysiology of light phenotype SARS-CoV-2 interstitial pneumonia: from histopathological features to clinical presentations. Pulmonology 2022; 28: 333-344. https:\/\/doi.org\/10.1016\/j.pulmoe.2021.03.003","DOI":"10.1016\/j.pulmoe.2021.03.003"},{"key":"10.32074\/1591-951X-954_ref112","doi-asserted-by":"crossref","unstructured":"Wang Y, Liu M, Guo X, et al. Endogenous Retrovirus Elements Are Co-Expressed with IFN Stimulation Genes in the JAK-STAT Pathway. Viruses 2022; 15: 60. https:\/\/doi.org\/10.3390\/v15010060","DOI":"10.3390\/v15010060"},{"key":"10.32074\/1591-951X-954_ref113","doi-asserted-by":"crossref","unstructured":"Blond JL, Bes\u00e8me F, Duret L, et al. Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J Virol 1999; 73: 1175-85. https:\/\/doi.org\/10.1128\/JVI.73.2.1175-1185.1999","DOI":"10.1128\/JVI.73.2.1175-1185.1999"},{"key":"10.32074\/1591-951X-954_ref114","doi-asserted-by":"crossref","unstructured":"Holder BS, Tower CL, Abrahams VM, et al. Syncytin 1 in the human placenta. Placenta 2012; 33: 460-466. https:\/\/doi.org\/10.1016\/j.placenta.2012.02.012","DOI":"10.1016\/j.placenta.2012.02.012"},{"key":"10.32074\/1591-951X-954_ref115","doi-asserted-by":"crossref","unstructured":"Mangeney M, Renard M, Schlecht-Louf G, et al. Placental syncytins: Genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins. Proc Natl Acad Sci U S A 2007; 104: 20534-9. https:\/\/doi.org\/10.1073\/pnas.0707873105","DOI":"10.1073\/pnas.0707873105"},{"key":"10.32074\/1591-951X-954_ref116","doi-asserted-by":"crossref","unstructured":"Qiao S, Wang F, Chen H, et al. Inducible knockout of Syncytin-A gene leads to an extensive placental vasculature deficiency, implications for preeclampsia. Clin Chim Acta 2017; 474: 137-146. https:\/\/doi.org\/10.1016\/j.cca.2017.09.012","DOI":"10.1016\/j.cca.2017.09.012"},{"key":"10.32074\/1591-951X-954_ref117","doi-asserted-by":"crossref","unstructured":"Wang YN, Ye Y, Zhou D, et al. The Role of Syncytin in Placental Angiogenesis and Fetal Growth. Front Cell Dev Biol 2022; 10: 852561. https:\/\/doi.org\/10.3389\/fcell.2022.852561","DOI":"10.3389\/fcell.2022.852561"},{"key":"10.32074\/1591-951X-954_ref118","doi-asserted-by":"crossref","unstructured":"Yu M, Hu X, Pan Z, et al. Endogenous retrovirus-derived enhancers confer the transcriptional regulation of human trophoblast syncytialization. Nucleic Acids Res 2023; 51: 4745-4759. https:\/\/doi.org\/10.1093\/nar\/gkad109","DOI":"10.1093\/nar\/gkad109"},{"key":"10.32074\/1591-951X-954_ref119","doi-asserted-by":"crossref","unstructured":"Gasent Blesa J, Candel V. Cell-cell fusion as a potential target in cancer therapy. Ecancermedicalscience 2009; 3: 145. https:\/\/doi.org\/10.3332\/ecancer.2009.145","DOI":"10.3332\/ecancer.2009.145"},{"key":"10.32074\/1591-951X-954_ref120","doi-asserted-by":"crossref","unstructured":"Knerr I, Beinder E, Rascher W. Syncytin, a novel human endogenous retroviral gene in human placenta: evidence for its dysregulation in preeclampsia and HELLP syndrome. Am J Obstet Gynecol 2002; 186: 210-213. https:\/\/doi.org\/10.1067\/mob.2002.119636","DOI":"10.1067\/mob.2002.119636"},{"key":"10.32074\/1591-951X-954_ref121","doi-asserted-by":"crossref","unstructured":"Langbein M, Strick R, Strissel PL, et al. Impaired cytotrophoblast cell-cell fusion is associated with reduced Syncytin and increased apoptosis in patients with placental dysfunction. Mol Reprod Dev 2008; 75: 175-183. https:\/\/doi.org\/10.1002\/mrd.20729","DOI":"10.1002\/mrd.20729"},{"key":"10.32074\/1591-951X-954_ref122","doi-asserted-by":"crossref","unstructured":"Ruebner M, Strissel PL, Ekici AB, et al. Reduced syncytin-1 expression levels in placental syndromes correlates with epigenetic hypermethylation of the ERVW-1 promoter region. PLoS One 2013; 8: e56145. https:\/\/doi.org\/10.1371\/journal.pone.0056145","DOI":"10.1371\/journal.pone.0056145"},{"key":"10.32074\/1591-951X-954_ref123","doi-asserted-by":"crossref","unstructured":"Lee X, Keith JC Jr, Stumm N, et al. Downregulation of placental syncytin expression and abnormal protein localization in pre-eclampsia. Placenta 2001; 22: 808-812. https:\/\/doi.org\/10.1053\/plac.2001.0722","DOI":"10.1053\/plac.2001.0722"},{"key":"10.32074\/1591-951X-954_ref124","doi-asserted-by":"crossref","unstructured":"Zhuang XW, Li J, Brost BC, et al. Decreased expression and altered methylation of syncytin-1 gene in human placentas associated with preeclampsia. Curr Pharm Des 2014; 20: 1796-1802. https:\/\/doi.org\/10.2174\/13816128113199990541","DOI":"10.2174\/13816128113199990541"},{"key":"10.32074\/1591-951X-954_ref125","doi-asserted-by":"crossref","unstructured":"Braga L, Ali H, Secco I, et al. Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia. Nature 2021; 594: 88-93. https:\/\/doi.org\/10.1038\/s41586-021-03491-6","DOI":"10.1038\/s41586-021-03491-6"},{"key":"10.32074\/1591-951X-954_ref126","doi-asserted-by":"crossref","unstructured":"Logue JK, Franko NM, McCulloch DJ, et al. Sequelae in Adults at 6 Months After COVID-19 Infection. JAMA Netw Open 2021; 4: e210830. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.0830","DOI":"10.1001\/jamanetworkopen.2021.0830"},{"key":"10.32074\/1591-951X-954_ref127","doi-asserted-by":"crossref","unstructured":"Darcis G, Bouquegneau A, Maes N, et al. Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study. Int J Infect Dis 2021; 109: 209-216. https:\/\/doi.org\/10.1016\/j.ijid.2021.07.016","DOI":"10.1016\/j.ijid.2021.07.016"},{"key":"10.32074\/1591-951X-954_ref128","doi-asserted-by":"crossref","unstructured":"Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med 2021; 27: 601-615. https:\/\/doi.org\/10.1038\/s41591-021-01283-z","DOI":"10.1038\/s41591-021-01283-z"},{"key":"10.32074\/1591-951X-954_ref129","doi-asserted-by":"crossref","unstructured":"Augustin M, Schommers P, Stecher M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur 2021; 6: 100122. https:\/\/doi.org\/10.1016\/j.lanepe.2021.100122","DOI":"10.1016\/j.lanepe.2021.100122"},{"key":"10.32074\/1591-951X-954_ref130","doi-asserted-by":"crossref","unstructured":"Soriano JB, Murthy S, Marshall JC, et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 2022; 22: e102-e107. https:\/\/doi.org\/10.1016\/S1473-3099(21)00703-9","DOI":"10.1016\/S1473-3099(21)00703-9"},{"key":"10.32074\/1591-951X-954_ref131","doi-asserted-by":"crossref","unstructured":"Yan Z, Yang M, Lai CL. Long COVID-19 Syndrome: A Comprehensive Review of Its Effect on Various Organ Systems and Recommendation on Rehabilitation Plans. Biomedicines 2021; 9: 966. https:\/\/doi.org\/10.3390\/biomedicines9080966","DOI":"10.3390\/biomedicines9080966"},{"key":"10.32074\/1591-951X-954_ref132","doi-asserted-by":"crossref","unstructured":"Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol 2022; 23: 194-202. https:\/\/doi.org\/10.1038\/s41590-021-01104-y","DOI":"10.1038\/s41590-021-01104-y"},{"key":"10.32074\/1591-951X-954_ref133","doi-asserted-by":"crossref","unstructured":"Antoniou KM, Vasarmidi E, Russell AM, et al. European Respiratory Society statement on long COVID follow-up. Eur Respir J 2022; 60: 2102174. https:\/\/doi.org\/10.1183\/13993003.02174-2021","DOI":"10.1183\/13993003.02174-2021"},{"key":"10.32074\/1591-951X-954_ref134","doi-asserted-by":"crossref","unstructured":"Ravaglia C, Doglioni C, Chilosi M, et al. Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection. Eur Respir J 2022; 60: 2102411. https:\/\/doi.org\/10.1183\/13993003.02411-2021","DOI":"10.1183\/13993003.02411-2021"},{"key":"10.32074\/1591-951X-954_ref135","doi-asserted-by":"crossref","unstructured":"Lovelace MD, Varney B, Sundaram G, et al Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases. Neuropharmacology 2017; 112 (Pt B): 373-388. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.03.024","DOI":"10.1016\/j.neuropharm.2016.03.024"},{"key":"10.32074\/1591-951X-954_ref136","doi-asserted-by":"crossref","unstructured":"Braidy N, Grant R, Adams S, et al. Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons. Neurotox Res 2009; 16: 77-86. https:\/\/doi.org\/10.1007\/s12640-009-9051-z","DOI":"10.1007\/s12640-009-9051-z"},{"key":"10.32074\/1591-951X-954_ref137","doi-asserted-by":"crossref","unstructured":"Lugo-Huitr\u00f3n R, Ugalde Mu\u00f1iz P, Pineda B, et al. Quinolinic acid: an endogenous neurotoxin with multiple targets. Oxid Med Cell Longev 2013; 2013: 104024. https:\/\/doi.org\/10.1155\/2013\/104024","DOI":"10.1155\/2013\/104024"},{"key":"10.32074\/1591-951X-954_ref138","doi-asserted-by":"crossref","unstructured":"Gietl M, Burkert F, Seiwald S, et al. Interferon-gamma Mediated Metabolic Pathways in Hospitalized Patients During Acute and Reconvalescent COVID-19. Int J Tryptophan Res 2023; 16: 11786469231154244. https:\/\/doi.org\/10.1177\/11786469231154244","DOI":"10.1177\/11786469231154244"},{"key":"10.32074\/1591-951X-954_ref139","doi-asserted-by":"crossref","unstructured":"Apostolou E, Rizwan M, Moustardas P, et al. Saliva antibody-fingerprint of reactivated latent viruses after mild\/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis\/chronic fatigue syndrome. Front Immunol 2022; 13: 949787. https:\/\/doi.org\/10.3389\/fimmu.2022.949787","DOI":"10.3389\/fimmu.2022.949787"}],"container-title":["Pathologica"],"original-title":[],"link":[{"URL":"https:\/\/www.pathologica.it\/article\/view\/954","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T13:27:59Z","timestamp":1730813279000},"score":1,"resource":{"primary":{"URL":"https:\/\/old.pathologica.it\/article\/view\/954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":139,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,10]]}},"URL":"https:\/\/doi.org\/10.32074\/1591-951x-954","relation":{},"ISSN":["1591-951X"],"issn-type":[{"value":"1591-951X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]},"article-number":"1"}}